Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators

Published:2022-11-06 Issue:22 Volume:65 Page:15085-15101
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Guzelj Samo¹,Weiss Matjaž¹,Slütter Bram²,Frkanec Ruža³,Jakopin Žiga¹^ORCID

Affiliation:

1. Faculty of Pharmacy, University of Ljubljana, SI-1000 Ljubljana, Slovenia

2. Division of BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, 2333 CC Leiden, The Netherlands

3. Centre for Research and Knowledge Transfer in Biotechnology, University of Zagreb, 10000 Zagreb, Croatia

Funder

Javna Agencija za Raziskovalno Dejavnost RS

European Cooperation in Science and Technology

Hrvatska Zaklada za Znanost

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00808

Reference66 articles.

1. Key roles of adjuvants in modern vaccines

2. Approaching the Asymptote? Evolution and Revolution in Immunology

3. Vaccine Adjuvants: Putting Innate Immunity to Work

4. Applications of Immunomodulatory Immune Synergies to Adjuvant Discovery and Vaccine Development

5. TLR Cross-talk Confers Specificity to Innate Immunity

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic immune augmentation enabled by covalently conjugating TLR4 and NOD2 agonists;European Journal of Medicinal Chemistry;2024-11

2. Synergistic Targeting of Innate Receptors TLR7 and NOD2 for Therapeutic Intervention in Multiple Sclerosis;International Journal of Molecular Sciences;2024-07-07

3. NOD2 reduces the chemoresistance of melanoma by inhibiting the TYMS/PLK1 signaling axis;2024-06-14

4. Chimeric NOD2 Mincle Agonists as Vaccine Adjuvants;Journal of Medicinal Chemistry;2024-03-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3